Multi-vessel off-pump coronary artery bypass grafting (OPCAB) changes the equipment conversation. A straightforward LAD case may be discussed around one stabilizer applied to the anterior target. Lateral and posterior wall targets are different: the heart often needs to be positioned away from its resting orientation while the target vessel zone is stabilized for the anastomosis.
That is why this page should not be written as a simple product comparison. The stronger and safer public angle is dual-stabilizer architecture: heart positioning and target-vessel stabilization are two coordinated functions, and the distributor should understand which standoff and foot combinations are being evaluated.
The architectural question: two functions, not one device claim
In a lateral-wall OPCAB discussion, it is useful to separate the functional roles:
- Heart positioning role: supporting exposure by lifting, rotating, or holding the heart in a selected position according to the surgeon’s approach and patient condition.
- Target stabilization role: locally stabilizing the coronary target territory for distal anastomosis according to IFU and surgical protocol.
Public copy should avoid saying that one specific configuration “makes multi-vessel OPCAB possible,” “improves hemodynamics,” or is clinically equivalent to a named competitor platform. Those statements require tightly defined evidence, comparator, and claim review. A safer statement is: dual-stabilizer OPCAB separates positioning from target stabilization, and AeroMed’s standoff / foot architecture allows these roles to be discussed within one product family.
For distributor education, the key message is not “one product replaces another.” The key message is: two clinical functions require a clear standoff and foot-selection plan.
AeroMed architecture: standoff family + stabilizer foot family
The AeroMed Heart Stabilizer portfolio can be explained as a modular architecture. The standoff provides reach, articulation, and locking. The foot defines the working role at the tissue interface. That does not mean every foot can be used for every role; selection must follow current IFU, labeling, model scope, surgeon judgment, and hospital protocol.
| Configuration element | Public explanation | Distributor verification |
|---|---|---|
| HK-Fy / HK-Fy-R(II) | Single-use standoff configurations for selected sternotomy OPCAB workflows according to current documentation. | Confirm exact model, length, compatible foot, IFU, label, packaging, and market documentation. |
| HK-GDQ-Q / HK-GDQ-Z | Reusable stabilizer-frame / standoff configurations for selected cardiac surgery workflows according to current documentation. | Confirm mounting interface, reusable-processing requirements, IFU, label, and certificate scope. |
| SF-VII | Stabilizer-foot option for selected heart-positioning or verticalization discussion. | Confirm intended role, suction source, tissue condition, IFU wording, and target territory. |
| SF-III / SF-IV | Vacuum-based stabilizer-foot options for local target-territory stabilization. | Confirm target vessel, foot geometry, vacuum requirement, IFU, label, and surgeon preference. |
| SF-V | Mechanical-pressure stabilizer-foot option where appropriate and documented. | Confirm tissue condition, target use, IFU wording, and whether vacuum-independent workflow is clinically appropriate. |
Avoid public wording such as “equivalent to Octopus + Starfish,” “reduces hemodynamic instability,” “same clinical evidence base,” “one CE file covers every configuration identically,” or “foot exchange is always intraoperative.” Use model-specific, IFU-led wording instead.
Why lateral and posterior targets change the configuration discussion
Anterior-wall targets are usually easier to expose from a median sternotomy approach. Lateral and posterior targets often require more heart positioning, and the stabilization point may not align with the same axis used for exposure. From a product-architecture perspective, that is the reason the two roles should be discussed separately.
A public article can explain the principle without becoming a surgical manual:
- One configuration may be used to help position the heart for exposure.
- A second configuration may be used to stabilize the target coronary territory.
- Foot choice should follow target anatomy, tissue condition, available suction, IFU, and surgeon judgment.
- The sternal retractor, suture holder, standoff, and foot should be discussed as a documented system configuration, not as isolated SKUs.
Foot pairing: safe public matrix
The following matrix is designed for public product education. It should not be treated as an operative instruction or fixed clinical protocol.
| Functional need | AeroMed foot discussion | Public wording |
|---|---|---|
| Heart positioning / verticalization discussion | SF-VII | For selected heart-positioning or verticalization workflows according to current IFU and surgeon judgment. |
| Target-vessel stabilization · vacuum-based | SF-III / SF-IV | For selected local tissue stabilization near the coronary target according to current IFU, vacuum availability, and target territory. |
| Target-vessel stabilization · mechanical | SF-V | For selected mechanical-pressure stabilization discussion where appropriate and documented; not a heart-positioning foot. |
| Redo / adhesion-affected anatomy discussion | Vacuum-foot evaluation | Discuss conservatively as a surgeon-led selection issue; do not make public claims about preserving myocardial mechanics or reducing complications unless evidence is available. |
How to discuss competitor products safely
The Medium version of this topic uses well-known category references such as Octopus and Starfish to explain the historical two-product-line approach. That can be useful for readers who already know the cardiac stabilizer market. On AeroMed’s public website, however, named competitor comparisons should stay category-level and non-claiming.
Safe framing:
- “Some established OPCAB platforms separate tissue stabilization and heart positioning into distinct product lines.”
- “AeroMed’s portfolio can be discussed as a standoff family plus selected stabilizer-foot configurations.”
- “Named third-party products are referenced only for category context and do not imply affiliation, endorsement, clinical equivalence, or replacement.”
This avoids turning a useful architecture explanation into an unsupported comparative claim.
Distributor quotation checklist
Before quoting a dual-stabilizer OPCAB configuration, distributors should collect the following information:
- Target procedure type: LAD-only OPCAB, multi-vessel OPCAB, lateral-wall targets, posterior-wall targets, redo OPCAB, or MICS / MIDCAB discussion.
- Standoff preference: single-use HK-Fy / HK-Fy-R(II), reusable HK-GDQ-Q / HK-GDQ-Z, or mixed evaluation.
- Foot selection: SF-VII for positioning discussion; SF-III / SF-IV / SF-V for target stabilization discussion where appropriate.
- Mounting configuration: sternal retractor, disposable suture holder, table-side mounting, or other documented interface.
- Documentation package: catalog pages, model matrix, IFU, label, product photos, packaging information, CE documentation, FDA documentation where applicable, and quotation terms.
- Commercial details: sample requirement, case category, target country, quantity, shipping destination, lead time, and quotation validity.
Regulatory and documentation logic
Public regulatory wording should remain conservative: CE documentation available according to current certificate and model scope, and FDA documentation where applicable. Avoid saying that all standoffs, all feet, all mounting accessories, and all configurations are covered identically unless the current certificate, IFU, label, and model list confirm it.
For qualified distributors, AeroMed can provide product-specific documentation according to target country, standoff type, stabilizer-foot selection, and inquiry type. This is the appropriate path for distributor due diligence, hospital evaluation, registration support, and quotation.
How this connects to the AeroMed cardiac portfolio
Dual-stabilizer OPCAB is not only a Heart Stabilizer page topic. It connects several cardiac product pages:
- Heart Stabilizer: overall OPCAB stabilizer system narrative and use boundary.
- Stabilizer Foot: SF-III / SF-IV / SF-V / SF-VII foot-selection logic.
- HK-GDQ reusable frame: reusable stabilizer-frame discussion for selected workflows.
- Sternal Retractor and Disposable Suture Holder: mounting and support accessories in selected sternotomy workflows.
This is why the page should act as a bridge between clinical scenario language and product-family navigation. The goal is not to overclaim clinical performance; the goal is to help distributors ask the right configuration and documentation questions.